Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29285409 | 0.83 | LMNA (0.35) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL28354300 | 0.78 | LMNA (0.36) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4180816 | 0.77 | KDM4E (0.33) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL27895862 | 0.76 | SMN1; SMN2 (0.33) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL27966008 | 0.75 | KDM4E (0.31) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3981875 | 0.74 | KDM4E (0.32) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL6034519 | 0.73 | LMNA (0.38) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL27561102 | 0.72 | LMNA (0.42) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL11005864 | 0.71 | LMNA (0.36) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL6753286 | 0.71 | LMNA (0.36) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104722301-B | A kind of selective glycerol aoxidizes the preparation method and applications method of the catalyst of dihydroxy acetone processed | 浙江工业大学之江学院 | 2017-01-04 | — | — | CN | disclosed |
| CN-1694690-A | Combination chemotherapy compositions and methods | NOVOGEN RES PTY LTD (AU) | 2005-11-09 | — | — | CN | disclosed |
| US-20030157225-A1 | Food product and process | NOVOGEN RESEARCH PTY LIMITED (AU) | 2003-08-21 | — | — | US | disclosed |
| EP-1254132-A4 | FOOD PRODUCT AND PROCESS | NOVOGEN RES PTY LTD (AU) | 2003-04-16 | — | — | EP | disclosed |
| EP-1063990-A4 | THERAPY OF ESTROGEN-ASSOCIATED DISORDERS | NOVOGEN RES PTY LTD (AU) | 2003-01-02 | — | — | EP | disclosed |
| EP-1254132-A1 | FOOD PRODUCT AND PROCESS | Novogen Research Pty. Ltd. (AU) | 2002-11-06 | — | — | EP | disclosed |
| WO-2001053285-A1 | FOOD PRODUCT AND PROCESS | NOVOGEN RESEARCH PTY LIMITED (AU) | 2001-07-26 | — | — | WO | disclosed |
| EP-1063990-A1 | THERAPY OF ESTROGEN-ASSOCIATED DISORDERS | Novogen Research Pty. Ltd. (AU) | 2001-01-03 | — | — | EP | disclosed |
| WO-1999048496-A1 | THERAPY OF ESTROGEN-ASSOCIATED DISORDERS | NOVOGEN RESEARCH PTY. LTD. (AU) | 1999-09-30 | — | — | WO | disclosed |